Get the latest Science News and Discoveries
Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD talks about AI and robotics in healthcare breakthroughs in ... - EurekAlert
Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, will be attending a series of meetings in the following week, where he will be discussing bioscience innovations powered by AI and robotics.
None
Or read this on Eureka Alert